Biotech Amyris: ‘We Have Built The Fastest-Growing Consumer Business In Health, Beauty And Wellness’
Executive Summary
Emeryville, CA-based Amyris launches the Stripes menopause care line with actress Naomi Watts, as well as Gen Z-targeted EcoFabulous skin care and cosmetics, acquired last year. The biotech projects its burgeoning Consumer business will grow more than 150% in 2022.
You may also be interested in...
In Bankruptcy, Amyris To Sell Consumer Brands, Turn Focus To Smaller Ingredients Business
Synthetic biotech company Amyris files for Chapter 11 bankruptcy for its multiple US corporate entities and plans to sell its consumer brands.
Biotech Amyris Raises Q1 Guidance, Closes On Givaudan Deal
Emeryville, Calif.-based synthetic biotechnology firm Amyris Inc. is raising its first quarter revenue guidance 12% to $56m as its new Brazilian biomanufacturing facility is delivering product at target. The firm also reports it has closed on its $500m deal with Givaudan SA.
Givaudan Strikes Deal For Amyris Ingredients, Long-Term Partnership
The deal has Amyris selling three key cosmetic ingredients to Givaudan and producing more biotech ingredients for the Swiss firm over the long term. “In the future, we will continue to push the boundaries of biotech, creating new sustainable innovations for a better beauty future,” says Givaudan’s Maurizio Volpi, president, Fragrance and Beauty.